TY - JOUR
T1 - Sleep-related disorders in patients with precapillary pulmonary hypertension
AU - Chao, Hsin Yu
AU - Yee, Brendon J.
AU - Hsu, Chih Hsin
AU - Chen, Hsing Mei
AU - Lau, Edmund M.
N1 - Publisher Copyright:
© 2024 Elsevier Ltd
PY - 2024/10
Y1 - 2024/10
N2 - Precapillary pulmonary hypertension (PcPH) is associated with the development of sleep-related disorders and impairment of sleep quality. With growing recognition of the clinical relevance of sleep-related conditions in PcPH, this narrative review seeks to discuss the spectrum of disorders encountered in clinical practice, pathophysiological mechanisms linking PcPH with sleep-related disorders, and potential therapeutic considerations. Current evidence demonstrates a higher prevalence of impaired sleep quality, sleep-disordered breathing, sleep-related hypoxia, and restless leg syndrome in patients with PcPH. These sleep-related disorders could further lead to impairment of quality of life in a patient population with already a high symptom burden. Recent data suggest that sleep-related hypoxia is strongly linked to worse right ventricular function and higher risk of transplantation or death. However, limited studies have investigated the role of oxygen therapy or positive airway pressure therapy improving symptoms or outcomes. Abnormal iron homeostasis is highly prevalent in PcPH and may contribute to the development of restless legs syndrome/periodic limb movement of sleep. To improve sleep management in PcPH, we highlight future research agenda and advocate close collaboration between pulmonary hypertension specialists and sleep physicians.
AB - Precapillary pulmonary hypertension (PcPH) is associated with the development of sleep-related disorders and impairment of sleep quality. With growing recognition of the clinical relevance of sleep-related conditions in PcPH, this narrative review seeks to discuss the spectrum of disorders encountered in clinical practice, pathophysiological mechanisms linking PcPH with sleep-related disorders, and potential therapeutic considerations. Current evidence demonstrates a higher prevalence of impaired sleep quality, sleep-disordered breathing, sleep-related hypoxia, and restless leg syndrome in patients with PcPH. These sleep-related disorders could further lead to impairment of quality of life in a patient population with already a high symptom burden. Recent data suggest that sleep-related hypoxia is strongly linked to worse right ventricular function and higher risk of transplantation or death. However, limited studies have investigated the role of oxygen therapy or positive airway pressure therapy improving symptoms or outcomes. Abnormal iron homeostasis is highly prevalent in PcPH and may contribute to the development of restless legs syndrome/periodic limb movement of sleep. To improve sleep management in PcPH, we highlight future research agenda and advocate close collaboration between pulmonary hypertension specialists and sleep physicians.
UR - http://www.scopus.com/inward/record.url?scp=85198704774&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85198704774&partnerID=8YFLogxK
U2 - 10.1016/j.smrv.2024.101972
DO - 10.1016/j.smrv.2024.101972
M3 - Review article
C2 - 39032322
AN - SCOPUS:85198704774
SN - 1087-0792
VL - 77
JO - Sleep Medicine Reviews
JF - Sleep Medicine Reviews
M1 - 101972
ER -